Jan 3 (Reuters) - Alliqua BioMedical Inc ALQA.O :
* ALLIQUA BIOMEDICAL CEO PROVIDES UPDATE TO SHAREHOLDERS
* ALLIQUA BIOMEDICAL INC - NEW COMPANY, TO PHARMA, IS
EXPECTED TO
TRADE ON NASDAQ AND WE ESTIMATE TRANSACTION WILL CLOSE IN Q1
* ALLIQUA BIOMEDICAL - AFTER SATISFYING MERGER EXPENSES ,
FINANCIAL COMMITMENTS, INTEND TO PAY SPECIAL DIVIDEND IN RANGE
OF $1.00 TO $1.20/SHARE
* ALLIQUA BIOMEDICAL INC - INTENT CONTINUES TO BE TO RETURN
ALL OF
UNUSED CAPITAL BACK TO SHAREHOLDERS
* ALLIQUA BIOMEDICAL INC - PROJECTED CASH DIVIDEND IS
SLIGHTLY
LOWER THAN ORIGINAL PROJECTION AT TIME OF ASSET SALE TO
CELULARITY IN MAY OF 2018
Source text for Eikon: ID:nGNX526CnS
Further company coverage: ALQA.O
((Reuters.Briefs@thomsonreuters.com;))